Mark Andrew Sherman
Evp, Gen. Counsel & Secretary at Dolby Laboratories, Inc. (DLB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 6,73875,425 held (−8%) | $66.58 | $449K | -10.0% |
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 2,37173,054 held (−3%) | $67.17 | $159K | -10.7% |
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 2,49170,563 held (−3%) | $67.26 | $168K | -10.9% |
| Dec 3SEC | DLBDolby Laboratories, Inc. | Sell Plan | 4,50062,397 held (−7%) | $67.56 | $304K | -11.3% |
- Sell
Evp, Gen. Counsel & Secretary Mark Andrew Sherman sold $449K of DLB at $66.58 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Gen. Counsel & Secretary Mark Andrew Sherman sold $159K of DLB at $67.17 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Gen. Counsel & Secretary Mark Andrew Sherman sold $168K of DLB at $67.26 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Gen. Counsel & Secretary Mark Andrew Sherman sold $304K of DLB at $67.56 — pre-scheduled 10b5-1 plan sale.